Skip to content

Pilot Remote Therapeutic Monitoring in Cancer Patients

Remote Therapeutic Monitoring: Pilot Implementation-Effectiveness Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07007039
Enrollment
25
Registered
2025-06-05
Start date
2025-09-08
Completion date
2027-04-01
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

exercise, activity tracking, rehabilitation, remote monitoring

Brief summary

The goal of this clinical trial is to learn about exercise and physical activity in individuals who are undergoing cancer treatment. The clinical trial is embedded in a pilot implementation feasibility study. The main implementation questions it aims to answer are to understand the implementation feasibility, acceptability and appropriateness of remote monitoring from providers and participants. The main clinical trial outcomes are to explore the effectiveness of remote therapeutic monitoring to achieve individual goal attainment related to exercise defined as number of daily steps, weekly exercise minutes, strength sessions or decreased physical activity variability. During the course of the study: Participants will use activity trackers and a mobile phone application to monitor their exercise participation over 3 months.

Detailed description

The study aims to evaluate the implementation and clinical effectiveness of Remote Therapeutic Monitoring (RTM) in cancer rehabilitation. RTM is a reimbursable tool that enables clinicians (physical therapists, occupational therapists, and physicians) to remotely monitor adherence to exercise and physical activity (PA), addressing barriers such as limited time and energy for in-person appointments during cancer treatment. We will implement three months of RTM in 20 individuals undergoing or within six months of chemotherapy, immunotherapy, or cell therapy. We will evaluate the following aims: 1\. Implementation Outcomes: Assess RTM's feasibility, acceptability, appropriateness, sustainability, and satisfaction from the perspectives of therapists, physicians, and patients using validated questionnaires and interviews. 2: Clinical Trial Outcomes: Measure RTM's effectiveness in achieving patient-centered goals, such as increasing or maintaining exercise, PA, strength training, or energy conservation, and its impact on quality of life using PROMIS-29+2. The findings will inform future large-scale research and enhance cancer rehabilitation outcomes by improving accessibility and personalized care through RTM integration.

Interventions

OTHERDatos Health App

Tracking participants step activity, workout frequency, minutes in target heart rate zone, and/or strength bouts completed over 3 month period. Individualized goals will be selected and set with a customized amount by a rehabilitation provider with at least monthly follow up contact to modify goals.

Sponsors

Shirley Ryan AbilityLab
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

* Are ambulatory as their primary means of mobility without an assistive device except for single point cane or walking sticks in community * Have a diagnosis of cancer (undergoing chemo, radiation, surgery, immunotherapy, or cell therapy (transplants and Chimeric Antigen Receptor t-cell therapy (CAR-T)) or in cancer survivorship * Participating in Outpatient rehabilitation services at time of enrollment, or recommended by physician for participation in study * Have a goal to increase or maintain physical activity (e.g., steps per day or minutes of moderate to vigorous exercise per week) or strength bouts - personal goal and willingness to address physical activity * Have a smart phone * Willing to accept Datos' Terms and Conditions

Exclusion criteria

* o Individuals with cognitive or communication disorders (including dementia) which would limit their ability to interact with the RTM in this pilot phase

Design outcomes

Primary

MeasureTime frameDescription
Physical Activity Metric 1Daily, through study completion, average 3 monthssteps per day
PROMIS 29+2completed at baseline and at study completion, average of 3 monthsA self report survey used to assess health report quality of life. It contains 31 total questions.

Secondary

MeasureTime frameDescription
Physical Activity Metric 2Daily, through study completion, average 3 monthsminutes of exercise in target heart rate zone
Physical Activity Metric 3weekly, through study completion, average 3 monthsNumber of strength training bouts

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORMiriam Rafferty, PT, DPT, PhD

Shirley Ryan AbilityLab

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 21, 2026